ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery

How One Tiny Molecule Turned into One Huge Health Breakthrough

Nutrients Boost Stem Cell Function

Humans have three times more brown body fat

B12 Proven Essential for Every Cell

Soy isoflavones may benefit breast cancer patients

How B Vitamins Improve Brain Health, Cognition, Psychiatric Problems and Mood Disorders

Dietary prebiotics improve sleep, buffer impacts of stress, says study

Ylang Ylang Oil Not Only Soothes Your Skin, but Your Mind as Well

Exercises to Help Prevent Urinary Incontinence

Print Page
Email Article

New Osteoarthritis Study Finds Newer NSAID Mobicox Well Tolerated

  [ 57 votes ]   [ Discuss This Article ] • July 25, 2001

A recent managed care, clinical trial reported that Mobicox (meloxicam), a COX-II selective NSAID used for symptomatic treatment of rheumatoid arthritis and painful osteoarthritis, showed significantly greater "patient success" than other commonly-used prescription NSAIDs.

The randomized study, which compared Mobicox to "usual care," or whatever prescription-NSAID patients' individual physicians selected as their osteoarthritis treatment, was presented for the first time last month at the Annual European Congress of Rheumatology in Prague, Czech Republic.

The usual care treatment group included other prescription osteoarthritis medicines, such as: piroxicam, diclofenac, naproxen, Celebrex (celecoxib) and Vioxx (rofecoxib).

"The difference in patient success between Mobicox and the usual care NSAID group is clinically meaningful and important information for both patients and physicians," said Gurkirpal Singh, MD, Professor of Medicine Immunology and Rheumatology, Stanford University Medical School and an investigator in the trial.

"Patients taking Mobicox were considerably more satisfied with their treatment, which suggests to us that Mobicox is an important treatment alternative for osteoarthritis - one that seems to work well and that patients can tolerate."

The trial, called "IMPROVE" (Impact of Meloxicam on Prescription Regimens
in Osteoarthritis vs. Everyday Care), found that more than two-thirds (67 per cent) of patients taking Mobicox were classified as successes, compared to less than half (45 per cent) of patients in the usual care group, with a range from 22 per cent to 62 per cent. Treatment success was defined as patients completing the trial without changing treatments, or those who no longer needed an NSAID for their osteoarthritis care.

"Products such as MOBICOX represent a promising new generation of NSAID-
class drugs," said John Wallace, Ph.D., Professor of Pharmacology & Therapeutics, University of Calgary. "Unlike older NSAIDs which have significant side effects, new products target particular enzymes to reduce pain and inflammation, while limiting the impact on enzymes that protect the lining of the stomach. Studies have shown that these targeted products result in fewer complications for patients."

The IMPROVE trial followed more than 1,300 osteoarthritis patients for six months and measured patient satisfaction and treatment success, as defined above. Half of the enrolled patients were prescribed Mobicox, and the other half was given whatever prescription-NSAID (other than Mobicox) their individual doctors selected, referred to as "everyday care."

"The IMPROVE trial is unique because we went directly to the patients and asked them how satisfied they were with their medical care for their osteoarthritis," said Dr. Singh. "In the practice of medicine, the most important thing is what works for the patient, and this is the first time we explicitly measured that in an arthritis study."
As with many osteoarthritis patients in the "real world," the primary reasons for study patients changing or discontinuing their NSAID treatment were lack of efficacy or the presence of adverse events, such as intolerable gastrointestinal (stomach) side effects. After six months of therapy, fewer osteoarthritis patients taking Mobicox discontinued or switched their treatment because of lack of efficacy or side effects, including gastrointestinal (GI) side effects, compared to patients treated with other commonly used NSAIDs. In addition, when patients rated their satisfaction with their osteoarthritis care after one and six months of therapy, patients taking Mobicox were significantly more satisfied than those taking the usual care NSAIDs.

"We know that some NSAIDs have been associated with unsatisfactory side effects and that some can cause unbearable stomach problems," said Ken Croitoru, MD, Professor of Medicine, Division of Gastroenterology, McMaster University.

Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

NAD+ Ignite with Niagen

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!
Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?
The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery
Restore Youthful Cognition and Well-Being Restore Youthful Cognition and Well-Being

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map